A randomized phase II trial of CHOP versus ICED and autologous stem cell transplantation in newly diagnosed T‐cell lymphoma.

Autor:	Yoo, K. H., Kim, S. J., Jo, J., Yoon, D. H., Yang, D., Yoon, S. E., Lee, G., Park, Y., Kang, K., Lee, H., Oh, S. Y., Shin, H., Kang, H. J., Lee, W. S., Choi, Y. S., Jeong, S. H., Kim, M. K., Yi, J. H., Lim, S., Yhim, H.
Předmět:	T-cell lymphoma STEM cell transplantation ANAPLASTIC large-cell lymphoma DIAGNOSIS
Zdroj:	Hematological Oncology; Jun2023 Supplement S2, Vol. 41, p497-499, 3p
Abstrakt:	Patients with ALK-positive ALCL, extranodal NK/T-cell lymphoma, and mycosis fungoides/sezary syndrome were not included in the study. CHOP was favored over ICED in AITL patients, whereas ICED was favored over CHOP in EATL/HSTL patients. B Purpose: b Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of non-Hodgkin lymphomas, and their prognoses are still poor because of frequent relapses and the absence of optimal standard therapy. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text